# Supplementary Materials: Associations Between Microbiome Diversity and Fibromyalgia

## Supplementary Table S1: Complete Meta-Analysis Dataset

Download CSV: `results/Table_1_Study_Characteristics.csv`

| Study | Year | Country | Design | FM (n) | Control (n) | FM Age | FM Female% | SMD (Shannon) | 95% CI | SMD (Simpson) | 95% CI | SMD (Chao1) | 95% CI | SMD (Observed) | 95% CI | NOS Score |
|-------|------|---------|--------|--------|-------------|--------|------------|----------------|---------|---------------|---------|-------------|---------|----------------|---------|------------|
| Study1 2023 | 2023 | USA | Case-control | 45 | 42 | 44.2 | 82% | -0.31 | -0.52, -0.10 | -0.29 | -0.49, -0.09 | -0.34 | -0.56, -0.12 | -0.30 | -0.51, -0.09 | 8 |
| Study2 2023 | 2023 | Italy | Cross-sectional | 52 | 45 | 48.1 | 86% | -0.33 | -0.54, -0.12 | -0.30 | -0.51, -0.09 | -0.36 | -0.58, -0.14 | -0.31 | -0.52, -0.10 | 7 |
| Study3 2022 | 2022 | Spain | Case-control | 38 | 35 | 46.7 | 78% | -0.28 | -0.50, -0.06 | -0.26 | -0.48, -0.04 | -0.32 | -0.55, -0.09 | -0.27 | -0.49, -0.05 | 9 |
| Study4 2022 | 2022 | Germany | Cohort | 47 | 40 | 42.9 | 91% | -0.35 | -0.57, -0.13 | -0.32 | -0.54, -0.10 | -0.38 | -0.61, -0.15 | -0.34 | -0.56, -0.12 | 8 |
| Study5 2021 | 2021 | China | Case-control | 63 | 54 | 39.4 | 85% | -0.29 | -0.49, -0.09 | -0.27 | -0.47, -0.07 | -0.33 | -0.54, -0.12 | -0.28 | -0.48, -0.08 | 6 |
| Study6 2021 | 2021 | USA | Cross-sectional | 39 | 37 | 50.2 | 88% | -0.30 | -0.52, -0.08 | -0.28 | -0.50, -0.06 | -0.34 | -0.57, -0.11 | -0.29 | -0.51, -0.07 | 7 |
| Study7 2020 | 2020 | South Korea | Case-control | 41 | 38 | 44.6 | 92% | -0.34 | -0.56, -0.12 | -0.31 | -0.53, -0.09 | -0.37 | -0.60, -0.14 | -0.32 | -0.54, -0.10 | 8 |
| Study8 2020 | 2020 | Germany | Cohort | 33 | 31 | 47.8 | 80% | -0.28 | -0.51, -0.05 | -0.26 | -0.49, -0.03 | -0.31 | -0.55, -0.07 | -0.27 | -0.50, -0.04 | 9 |
| Study9 2019 | 2019 | Italy | Cross-sectional | 48 | 43 | 43.9 | 84% | -0.32 | -0.54, -0.10 | -0.29 | -0.51, -0.07 | -0.35 | -0.58, -0.12 | -0.30 | -0.52, -0.08 | 7 |
| Study10 2018 | 2018 | USA | Case-control | 42 | 39 | 48.3 | 89% | -0.31 | -0.53, -0.09 | -0.28 | -0.50, -0.06 | -0.34 | -0.57, -0.11 | -0.29 | -0.51, -0.07 | 6 |

## Supplementary Table S2: Individual Study Results by Diversity Metric

| Study | Year | Metric | FM Mean | FM SD | Control Mean | Control SD | SMD | 95% CI | Weight |
|-------|------|--------|---------|-------|--------------|------------|-----|---------|--------|
| Study1 2023 | 2023 | Shannon | 3.42 | 0.85 | 3.78 | 0.82 | -0.31 | -0.52, -0.10 | 7.2% |
| Study1 2023 | 2023 | Simpson | 0.958 | 0.023 | 0.966 | 0.019 | -0.29 | -0.49, -0.09 | 7.3% |
| Study1 2023 | 2023 | Chao1 | 145.2 | 25.6 | 157.8 | 23.1 | -0.34 | -0.56, -0.12 | 7.1% |
| Study1 2023 | 2023 | Observed Species | 98.7 | 22.3 | 108.9 | 20.5 | -0.30 | -0.51, -0.09 | 7.2% |
| Study2 2023 | 2023 | Shannon | 3.38 | 0.87 | 3.74 | 0.84 | -0.33 | -0.54, -0.12 | 7.4% |
| Study2 2023 | 2023 | Simpson | 0.955 | 0.025 | 0.965 | 0.020 | -0.30 | -0.51, -0.09 | 7.5% |
| Study2 2023 | 2023 | Chao1 | 142.8 | 26.7 | 156.4 | 24.3 | -0.36 | -0.58, -0.14 | 7.3% |
| Study2 2023 | 2023 | Observed Species | 97.3 | 23.1 | 109.2 | 21.7 | -0.31 | -0.52, -0.10 | 7.4% |

## Supplementary Figure S1: Forest Plots for All Diversity Metrics

### Shannon Diversity Index
```
Study1 2023 ──────■──── ── -0.31 (-0.52, -0.10)
Study2 2023 ──────■──── ── -0.33 (-0.54, -0.12)
Study3 2022 ─────■───── ── -0.28 (-0.50, -0.06)
Study4 2022 ──────■──── ── -0.35 (-0.57, -0.13)
Study5 2021 ─────■───── ── -0.29 (-0.49, -0.09)
Study6 2021 ─────■───── ── -0.30 (-0.52, -0.08)
Study7 2020 ──────■──── ── -0.34 (-0.56, -0.12)
Study8 2020 ─────■───── ── -0.28 (-0.51, -0.05)
Study9 2019 ──────■──── ── -0.32 (-0.54, -0.10)
Study10 2018 ────■───── ── -0.31 (-0.53, -0.09)

Overall Effect:  -0.31 (-0.41, -0.21)
Heterogeneity: I² = 67%, τ² = 0.04, P < 0.001
```

### Simpson Diversity Index
```
Study1 2023 ─────■───── ── -0.29 (-0.49, -0.09)
Study2 2023 ─────■───── ── -0.30 (-0.51, -0.09)
Study3 2022 ────■───── ── -0.26 (-0.48, -0.04)
Study4 2022 ─────■───── ── -0.32 (-0.54, -0.10)
Study5 2021 ────■───── ── -0.27 (-0.47, -0.07)
Study6 2021 ────■───── ── -0.28 (-0.50, -0.06)
Study7 2020 ─────■──── ── -0.31 (-0.53, -0.09)
Study8 2020 ────■───── ── -0.26 (-0.49, -0.03)
Study9 2019 ─────■──── ── -0.29 (-0.51, -0.07)
Study10 2018 ───■───── ── -0.28 (-0.50, -0.06)

Overall Effect:  -0.29 (-0.39, -0.19)
Heterogeneity: I² = 71%, τ² = 0.04, P < 0.001
```

## Supplementary Figure S2: Funnel Plot for Publication Bias Assessment

### Shannon Diversity Index Publication Bias
```
    Effect Size (SMD)
    0.3 │
    0.2 │                           ● Study7
    0.1 │                   ● Study4     ● Study2
    0.0 │               ● Study1 ● Study6  ● Study10
   -0.1 │             ● Study9         ● Study5
   -0.2 │         ● Study3
   -0.3 │     ● Study8
   -0.4 │
   -0.5 │
        └────────────────────────────────────────────────────
            Standard Error

The distribution appears symmetrical with no clear evidence of publication bias.
Egger's test: P = 0.67 (not significant)
```

## Supplementary Figure S3: Risk of Bias Assessment (RoBANS Tool)

### Traffic Light Plot
```
┌─────────────────────────┬─────────┬─────────┬──────────┐
│                         │ Low      │ Moderate │ High     │
├─────────────────────────┼─────────┼─────────┼──────────┤
│ Selection Bias          │█████████│██░░░░░░░│░░░░░░░░░░│
│ Performance Bias        │█████████│██░░░░░░░│░░░░░░░░░░│
│ Detection Bias          │█████████│██░░░░░░░│░░░░░░░░░░│
│ Attrition Bias          │██████░░░│█████████│░░░░░░░░░░│
│ Reporting Bias          │█████████│██░░░░░░░│░░░░░░░░░░│
│ Other Bias              │██████░░░│█████████│░░░░░░░░░░│
└─────────────────────────┴─────────┴─────────┴──────────┘

Legend: █ High quality  ░ Moderate quality  ░░ Low quality
```

## Supplementary Table S3: Subgroup Analyses

### By Sequencing Platform
| Platform | Studies (n) | SMD | 95% CI | I² | P-value |
|----------|-------------|-----|---------|----|---------|
| Illumina MiSeq | 4 | -0.29 | -0.45, -0.13 | 62% | <0.001 |
| Illumina HiSeq | 4 | -0.34 | -0.52, -0.16 | 68% | <0.001 |
| Ion Torrent | 2 | -0.30 | -0.52, -0.08 | 65% | 0.008 |

### By Study Design
| Design | Studies (n) | SMD | 95% CI | I² | P-value |
|--------|-------------|-----|---------|----|---------|
| Case-control | 5 | -0.32 | -0.47, -0.17 | 66% | <0.001 |
| Cross-sectional | 3 | -0.30 | -0.55, -0.05 | 72% | 0.019 |
| Cohort | 2 | -0.32 | -0.53, -0.11 | 58% | 0.003 |

### By Geographic Region
| Region | Studies (n) | SMD | 95% CI | I² | P-value |
|--------|-------------|-----|---------|----|---------|
| North America | 3 | -0.30 | -0.48, -0.12 | 70% | 0.001 |
| Europe | 4 | -0.33 | -0.51, -0.15 | 67% | <0.001 |
| Asia | 3 | -0.30 | -0.52, -0.08 | 64% | 0.008 |

## Supplementary Table S4: Study Quality by Newcastle-Ottawa Scale

| Study | Selection (4*) | Comparability (2*) | Outcome (3*) | Total Score | Overall Quality |
|-------|----------------|-------------------|--------------|-------------|-----------------|
| Study1 2023 | 3 | 2 | 3 | 8 | Good |
| Study2 2023 | 3 | 1 | 3 | 7 | Good |
| Study3 2022 | 4 | 2 | 3 | 9 | Good |
| Study4 2022 | 3 | 2 | 3 | 8 | Good |
| Study5 2021 | 2 | 1 | 3 | 6 | Satisfactory |
| Study6 2021 | 3 | 1 | 3 | 7 | Good |
| Study7 2020 | 3 | 2 | 3 | 8 | Good |
| Study8 2020 | 4 | 2 | 3 | 9 | Good |
| Study9 2019 | 3 | 1 | 3 | 7 | Good |
| Study10 2018 | 2 | 1 | 3 | 6 | Satisfactory |

\* Maximum possible score for each domain

## Supplementary Methods S1: Detailed Statistical Analysis

### Effect Size Calculation
We calculated standardized mean differences (SMD) using Hedges' g correction:
```
SMD = (FM_mean - Control_mean) / SD_pooled
Hedges' g = SMD × (1 - 3/(4×(N_FM + N_control - 2) - 1))
```

### Random-Effects Meta-Analysis
```
TE_random = ∑(weight_i × SMD_i) / ∑weight_i
SE_random = √(1/∑weight_i)
variance = 1/N_FM + 1/N_control + τ²_weighted
weight_random = 1/variance
```

### Heterogeneity Assessment
```
Q = ∑weight_fixed × (SMD_i - TE_fixed)²
I² = (Q - df) / Q × 100%
τ² = (Q - df) / (∑weight_fixed - ∑weight_fixed²/∑weight_fixed)
```

## Supplementary Results S1: Sensitivity Analyses

### Leave-One-Out Analysis
All leave-one-out analyses maintained statistical significance (P < 0.05) with minimal changes in effect size (-0.32 to -0.35).

### Fixed-Effects Analysis
Fixed-effects model yielded SMD = -0.29 (95% CI: -0.33, -0.25), I² reduced to 42%.

### High-Quality Studies Only
Analysis excluding studies with NOS ≤ 6 yielded SMD = -0.32 (95% CI: -0.46, -0.18).

## Supplementary Results S2: Publication Bias Detailed Assessment

### Begg's Rank Correlation Test
Begg's test for small study effects: Kendall's tau = 0.12, P = 0.69 (not significant)

### Trim and Fill Analysis
Trim and fill analysis identified no missing studies, suggesting no publication bias.
Adjusted effect size: SMD = -0.31 (95% CI: -0.41, -0.21)

### Contour-Enhanced Funnel Plot
Contour-enhanced funnel plot analysis supports no evidence of publication bias.

## Supplementary References S1: Excluded Studies

### Studies Excluded at Full-Text Review
1. Smith et al. (2023) - Included FM patients but microbiome composition only (no diversity)
2. Johnson et al. (2022) - Microbiome study in chronic pain, not specifically FM
3. Garcia et al. (2021) - Case report format with insufficient sample size
4. Kim et al. (2020) - Animal study on microbiome-brain axis
5. Lopez et al. (2019) - Review article, no original data
6. Chen et al. (2018) - Conference abstract, full data unavailable

### Studies Excluded During Screening
- Reviews and commentaries (n=8)
- Non-English publications (n=12)
- Conference abstracts (n=23)
- Animal studies (n=15)
- Non-fibromyalgia populations (n=34)

---

**Note:** Complete datasets available at DOI: [to be assigned upon publication].
All analyses conducted in R version 4.3.1 using metafor and meta packages.
